Matrix metalloproteinases as candidate biomarkers in adults with congenital heart disease

References

• Aboulhosn JA, Lluri G, Gurvitz MZ, et al. (2013). Left and right ventricular diastolic function in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Can J Cardiol 29:866–72.
   PubMed Web of Science ®Google Scholar
• Ahmed SH, Clark LL, Pennington WR, et al. (2006). Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 113:2089–96.
   PubMed Web of Science ®Google Scholar
• Baker AH, Edwards DR, Murphy G. (2002). Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci 115:3719–27.
   PubMed Web of Science ®Google Scholar
• Bode W, Fernandez-Catalan C, Grams F, et al. (1999). Insights into MMP-TIMP interactions. Ann N Y Acad Sci 878:73–91.
   PubMed Web of Science ®Google Scholar
• Brown RD, Jones GM, Laird RE, et al. (2007). Cytokines regulate matrix metalloproteinases and migration in cardiac fibroblasts. Biochem Biophys Res Commun 362:200–5.
   PubMed Web of Science ®Google Scholar
• Chen CA, Tseng WY, Wang JK, et al. (2013). Circulating biomarkers of collagen type I metabolism mark the right ventricular fibrosis and adverse markers of clinical outcome in adults with repaired tetralogy of Fallot. Int J Cardiol 167:2963–8.
   PubMed Web of Science ®Google Scholar
• Chu JW, Jones GT, Tarr GP, et al. (2013). Plasma active matrix metalloproteinase 9 and indices of diastolic function in patients with preserved systolic function. Int J Cardiol 167:1242–6.
   PubMed Web of Science ®Google Scholar
• Diller GP, Dimopoulos K, Okonko D, et al. (2005). Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 112:828–35.
   PubMed Web of Science ®Google Scholar
• Dimopoulos K, Okonko DO, Diller GP, et al. (2006). Abnormal ventilatory response to exercise in adults with congenital heart disease relates to cyanosis and predicts survival. Circulation 113:2796–802.
   PubMed Web of Science ®Google Scholar
• Dusenbery SM, Jerosch-Herold M, Rickers C, et al. (2014). Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. J Am Coll Cardiol 63:1778–85.
   PubMed Web of Science ®Google Scholar
• Eindhoven JA, van den Bosch AE, Ruys TP, et al. (2013). N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease. J Am Coll Cardiol 62:1203–12.
   PubMed Web of Science ®Google Scholar
• Friedberg MK, Cho MY, Li J, et al. (2013). Adverse biventricular remodeling in isolated right ventricular hypertension is mediated by increased transforming growth factor-beta1 signaling and is abrogated by angiotensin receptor blockade. Am J Respir Cell Mol Biol 49:1019–28.
   PubMed Web of Science ®Google Scholar
• Friedman KG, Mcelhinney DB, Rhodes J, et al. (2013). Left ventricular diastolic function in children and young adults with congenital aortic valve disease. Am J Cardiol 111:243–9.
   PubMed Web of Science ®Google Scholar
• Gardin JM, Leifer ES, Fleg JL, et al. (2009). Relationship of Doppler-Echocardiographic left ventricular diastolic function to exercise performance in systolic heart failure: the HF-ACTION study. Am Heart J 158:S45–52.
   PubMed Web of Science ®Google Scholar
• Gross J, Lapiere CM. (1962). Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA 48:1014–22.
   PubMed Web of Science ®Google Scholar
• Ikonomidis JS, Ivey CR, Wheeler JB, et al. (2013). Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease. J Thorac Cardiovasc Surg 145:1326–33.
   PubMed Web of Science ®Google Scholar
• Jones JA, Mcnally AK, Chang DT, et al. (2008). Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials. J Biomed Mater Res A 84:158–66.
   PubMed Web of Science ®Google Scholar
• Kang SJ, Lim HS, Choi BJ, et al. (2008). Longitudinal strain and torsion assessed by two-dimensional speckle tracking correlate with the serum level of tissue inhibitor of matrix metalloproteinase-1, a marker of myocardial fibrosis, in patients with hypertension. J Am Soc Echocardiogr 21:907–11.
   PubMed Web of Science ®Google Scholar
• Konttinen YT, Ainola M, Valleala H, et al. (1999). Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 58:691–7.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. (2015). Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28:1–39 e14.
   PubMed Web of Science ®Google Scholar
• Laviades C, Varo N, Fernandez J, et al. (1998). Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 98:535–40.
   PubMed Web of Science ®Google Scholar
• Martos R, Baugh J, Ledwidge M, et al. (2007). Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115:888–95.
   PubMed Web of Science ®Google Scholar
• Morrow DA, de Lemos JA. (2007). Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 115:949–52.
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson WG, Liotta LA, Kleiner DE. JR. (1993). Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7:1434–41.
   PubMed Web of Science ®Google Scholar
• Vaday GG, Schor H, Rahat MA, et al. (2001). Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes. J Leukoc Biol 69:613–21.
   PubMed Web of Science ®Google Scholar
• Visse R, Nagase H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92:827–39.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu B, Dong L, et al. (2016). Circulating matrix metalloproteinase patterns in association with aortic dilatation in bicuspid aortic valve patients with isolated severe aortic stenosis. Heart Vessels 31:189–97.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wu D, Choi JC, et al. (2014). Matrix metalloproteinase levels in chronic thoracic aortic dissection. J Surg Res 189:348–58.
   PubMed Web of Science ®Google Scholar